Investors in Iot

X-Ventures is Hungary’s leading venture fund management company, coordinating the activities of X-Ventures Alpha Zrt. and three funds: Alpha, Beta, and Gamma. While primarily focusing on IT and biotechnology, the funds also invest in traditional sectors such as health care, logistics, electronics, and machinery. Besides providing capital, X-Ventures leverages its professional experience and extensive network to help portfolio companies achieve their full business potential.

Vespucci Partners is a Budapest-based venture capital fund focused on finding and supporting Central European startups with disruptive products and global market potential. They provide more than just financial backing, offering smart capital, portfolio management expertise, guidance, and a strong network for international expansion. With a fund size of 41 million EUR, Vespucci Partners targets Seed and Series A investments ranging from 600k to 4.5 million EUR, aiming to help startups achieve long-term success through a combination of sustainability principles, strategic support, and extensive industry experience.

Embed Capital offers financial and strategic consulting services to startups and SMEs, supporting digitalization and managing a diverse portfolio of over 20 investments.

Claris Ventures SGR makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence. We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence. Claris Biotech I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing" (or the relevant translation).

HTH is a Private Venture Capital Investment Company backed by Entrepreneur in the Healthcare Sector. The company provides capital to Early to Mid Stage companies with breakthrough technologies in Life Sciences. The company invests internationally and focuses on Medtech, Biotech, Digital Health and related fields.

Genextra is a privately owned holding company with investments in early-stage life science companies. Our mission is to identify innovative research in life science and to advance novel therapies and tools by creating successful business initiatives.

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development. We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.

Wellcome Trust is a global charitable foundation dedicated to improving health by funding scientific research. With a focus on both human and animal health, Wellcome Trust supports innovative projects and initiatives that aim to understand and address health challenges. The organization's funding extends across various disciplines, including biomedical science, public health, and medical innovation. Wellcome Trust's contributions play a crucial role in advancing medical knowledge, developing new treatments, and promoting global health equity. Through strategic investments and partnerships, Wellcome Trust continues to drive progress in healthcare, aiming to create a healthier future for all.

Cur8 Capital is a trading name of IFG.VC Limited, a subsidiary of Islamicfinanceguru Limited. IFG.VC Limited is authorised and regulated by the FCA (No. 943736). Cur8 Capital provides a platform showcasing various investment opportunities, though it does not promote any specific investment to the public. The information presented is meant to demonstrate the types of investments available. Detailed campaigns are accessible to authorised investors on the Cur8 Capital platform. Investment activities are confined to the United Kingdom, and potential investors outside the UK should verify local regulations. This page does not offer financial or tax advice, as tax treatment varies per individual circumstances and may change.

Synthesis Capital focuses on investing in visionary founders whose companies are pioneering the transformation of the food system. They specialize in integrating food technology and modern biotechnology to create innovative solutions that address key challenges in food production, sustainability, and nutrition. Synthesis Capital supports game-changing ventures that aim to revolutionize how we grow, process, and consume food, contributing to a more sustainable and resilient food ecosystem.

Cornerstone Venture Partners LLP, we are a London-based limited liability partnership registered in England and Wales under number OC440668. Our operations are centered at our registered office located at 10 Orange Street, Haymarket, London, WC2H 7DQ, United Kingdom. We proudly serve as an Appointed Representative of The Fund Incubator Limited, authorized and regulated by the Financial Conduct Authority (FCA) with firm reference number 208716